In this paper, we demonstrate that knockdown of CCDC26 in CML-derived K562 cells results in transcriptionally-altered expression of several genes, including activation of KIT, and prolonged cell survival under low or no serum conditions. The gene discussed is KIT; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.